( NASDAQ-SMALL:CTSO )

News from CytoSorbents Corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

07:05 ET CytoSorbents Introduces the CytoSorb Therapeutic ECMO™ Kit at the 2017 European Society of Intensive Care Medicine Congress

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using CytoSorb® blood purification to treat deadly inflammation in...


Sep 25, 2017, 07:15 ET Key Clinical Study Showing Reversal of Refractory Septic Shock in Patients Treated with CytoSorb®

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using CytoSorb® blood purification to treat deadly inflammation in...


Sep 14, 2017, 08:15 ET World Sepsis Day 2017: CytoSorbents Sponsors the Sepsis Update 2017 Congress and Sepsis Heroes Ceremony

CytoSorbents Corporation (NASDAQ: CTSO), a leader in critical care immunotherapy using its CytoSorb® blood purification technology to help patients...


Sep 11, 2017, 07:15 ET Aferetica and CytoSorbents Partner to Enhance the Success of Solid Organ Transplantation

Aferetica srl, an innovative start-up specializing in blood purification, and CytoSorbents Corporation (NASDAQ: CTSO), a critical care...


Sep 06, 2017, 07:00 ET CytoSorbents to Present at the 2017 Rodman & Renshaw Annual Global Investment Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to prevent or...


Sep 05, 2017, 08:05 ET CytoSorbents Highlights Important Research Advances in Traumatic Brain Injury, Hemorrhagic Shock, and Severe Hyperkalemia at the Military Health System Research Symposium

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to prevent or...


Aug 14, 2017, 07:15 ET CytoSorbents Awarded $719,000 Grant To Acutely Stabilize Severe Burn Patients

CytoSorbents Corporation (NASDAQ: CTSO), a leader in critical care immunotherapy specializing in blood purification, announced that it has been...


Aug 07, 2017, 16:15 ET CytoSorbents Reports Record Quarterly Total Revenue and Product Sales in the Second Quarter 2017

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to...


Aug 01, 2017, 07:00 ET CytoSorbents to Report Q2 2017 Operating and Financial Results

CytoSorbents Corporation (CTSO), CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood...


Jul 17, 2017, 09:15 ET CytoSorbents Expands Distribution and Sales of CytoSorb® to treat Deadly Inflammation in Panama with DRGR

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using CytoSorb® blood purification to treat deadly inflammation in...


Jul 13, 2017, 07:05 ET CytoSorbents Awarded $1 Million STTR Phase II Contract To Advance Development of Life-Saving Universal Plasma

CytoSorbents Corporation (NASDAQ: CTSO), a leader in critical care immunotherapy specializing in blood purification, today announced that...


Jul 05, 2017, 07:05 ET CytoSorbents Receives Additional $5 Million in Non-Dilutive Debt Financing from Bridge Bank

CytoSorbents Corporation (NASDAQ: CTSO), a leader in critical care immunotherapy specializing in blood purification, announced that on June 30,...


Jun 15, 2017, 07:05 ET CytoSorbents Announces Director and Management Open Market Stock Purchases

CytoSorbents Corporation (CTSO), a critical care immunotherapy leader using CytoSorb® blood purification to treat deadly inflammation in...


Jun 06, 2017, 09:48 ET CytoSorbents - A Leader in Blood Purification to Treat Deadly Inflammation - Teams with Investor Relations Firm LifeSci Advisors

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using CytoSorb® blood purification to treat deadly inflammation in...


May 30, 2017, 07:15 ET Dr. Eric R. Mortensen, M.D., Ph.D., Clinical Trial Veteran, Joins CytoSorbents as Chief Medical Officer

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using CytoSorb® blood purification to treat deadly inflammation...


May 24, 2017, 08:05 ET CytoSorbents Selected to Present at Special Operations SOMSA 2017 Conference and 18th Annual B. Riley & Co. Investor Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using CytoSorb® blood purification to treat deadly inflammation in...


May 22, 2017, 09:00 ET Aferetica and CytoSorbents Extend Exclusive "Life-saving" Partnership through 2021

Aferetica srl, an innovative start-up specializing in blood purification, and CytoSorbents Corporation (NASDAQ: CTSO), a critical care...


May 08, 2017, 16:30 ET CytoSorbents Reports First Quarter 2017 Financial Results

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to prevent or...


May 05, 2017, 09:00 ET CytoSorbents Announces Positive REFRESH I Trial Results

Positive results from the REFRESH (REduction in FREe Hemoglobin) I trial were presented on Monday, May 1, 2017 at the American Association for...


May 02, 2017, 07:00 ET CytoSorbents to Report Q1 2017 Operating and Financial Results

CytoSorbents Corporation (CTSO), CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood...


Apr 19, 2017, 08:30 ET CytoSorbents 2017 - Propelling the Company to the "Next Level"

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...


Mar 31, 2017, 08:00 ET CytoSorbents Announces Pricing of Follow-On Offering

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly...


Mar 30, 2017, 16:01 ET CytoSorbents Announces Proposed Offering of Common Stock

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly...


Mar 28, 2017, 07:15 ET CytoSorbents Strengthens Intellectual Property Portfolio with New Patents Issued in the U.S., China, Japan, Russia, and Australia

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...


Mar 27, 2017, 07:08 ET CytoSorbents REFRESH I Trial Abstract Selected for Podium Presentation at the American Association for Thoracic Surgery Centennial Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...